Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Mydecine Innovations Group Inc. Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound December 18, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers CSE:MYCO MYCOF Mydecine Provides Q4 2023 Business Update October 26, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers CSE:MYCO MYCOF Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings October 10, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Mydecine Announces Conditional Approval of CSE Listing August 30, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors May 29, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Mydecine Reports its 2023 Annual General Shareholders' Meeting Results May 10, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues April 24, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Mydecine Innovations Group Provides Corporate Update April 03, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Mydecine Reports Financial Results for the Year Ended December 2022 March 31, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc. December 12, 2022 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers CSE:NARA MYCOF Mydecine Reports Financial Results for the Third Quarter of Fiscal Year 2022 November 14, 2022 From Mydecine Innovations Group Inc. Via GlobeNewswire Tickers MYCOF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.